<![CDATA[Objective: To describe the incidence of ovarian cancer and its characteristic
in Dr. Cipto Mangunkusumo Hospital in the last 5 years.
Method: This was cross sectional study design. The data was collected
from Gynecology Oncology Division Cancer Registry and Dr.
Cipto Mangunkusumo Hospital medical record from January 2009 to
December 2013; follow up was performed to know the 4-years survival
rate.
Result: There were 98 subjects in this study. The majority incidence
of ovarian cancer was 45-54 years old (33.6%); the incidence of
ovarian cancer decreased with the increased number of parity; the
majority histotype was epithelial (76.5%); and most of them were
diagnosed on advanced stage (55.1%). The 4-year survival rate for
epithelial type was 77%; germinal type was 83.3%; and stromal type
was 100%. Based on therapy, the 4-year survival rate was 84.1% for
surgical only; 83.3% in adjuvant chemotherapy group; and 68.4% in
neoadjuvant chemotherapy. In the group of adjuvant chemotherapy,
there was 63% patients with complete response and 41.2% patients
with complete response in neoadjuvant chemotherapy.
Conclusion: The highest incidence of ovarian cancer in Dr. Cipto
Mangunkusumo Hospital belongs to the age of reproductive women
(≤ 55 years old) with the highest incidence occurs in nulliparity women.
Most of the ovarian cancer cases are diagnosed in advanced
stage (stage III-IV).
[Indones J Obstet Gynecol 2016; 4-2: 101-106]
Keywords: age, histotype, ovarian cancer, parity, response, stage,
survival, treatment]]>
Copyrights © 2016
